期刊文献+

吸烟伴COPD患者肺组织中凋亡相关蛋白Bax与Bcl-2的表达 被引量:5

Expression of Apoptotic Proteins Bax and Bcl-2 in Alveolar Walls and Alveolar Macrophages in Smokers with COPD
下载PDF
导出
摘要 目的观察凋亡相关蛋白Bax与Bcl-2在吸烟伴慢性阻塞性肺疾病(COPD)患者与吸烟无COPD者肺组织中表达的差异性,探讨其在COPD发病中的作用。方法收集因肺部阴影行肺叶切除手术患者肺组织32例,其中吸烟伴COPD患者(A组)11例,吸烟无COPD者(B组)10例,不吸烟无COPD者(C组)11例,用免疫组化法(SP法)检测肺组织中Bax与Bcl-2蛋白的表达。结果 A组和B组肺泡间隔细胞中的Bax与Bcl-2阳性率、Bax/Bcl-2比值均明显高于C组(均P<0.05),A组肺泡间隔细胞中的Bax/Bcl-2比值明显高于B组(P<0.05)。肺泡间隔细胞中Bax阳性率、Bax/Bcl-2比值均与气流受限的肺功能指标(FEV1%pred,FEV1/FVC%)呈负相关。A组肺泡腔内巨噬细胞Bax/Bcl-2比值明显低于C组(P<0.05)。结论 Bax和Bcl-2在肺泡间隔细胞和肺泡腔内巨噬细胞表达的变化可能参与COPD发病机制。 Objective To investigate the expression of apoptotic proteins Bax and Bcl-2 in lung parenchyma of chronic obstructive pulmonary disease(COPD)patients and to explore the relationship between Bax/Bcl-2 ratio and COPD.Methods Surgically resected specimens from 11 smokers with COPD,10 smokers and 11 nonsmokers with normal lung function were analyzed.Markers of apoptosis including Bax and Bcl-2 proteins were detected by immunohistochemistry in both alveolar macrophages and alveolar walls.Results The Bax/Bcl-2 ratio was significantly higher in the pulmonary alveolar walls of smokers with COPD(P0.05),and it was inversely correlated with lung function.On the contrary,the Bax/Bcl-2 ratio in alveolar macrophages was significantly lower in smokers with COPD than in nonsmokers without COPD(P0.05),which may be one of the mechanisms contributing to less apoptosis of macrophages in COPD.Conclusion The changes of the Bax and Bcl-2 protein levels in the alveolar walls and macrophages may be involved in the pathogenesis of COPD.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期762-765,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 2007~2009年度卫生部部属(管)医院临床学科重点项目(No.2007-353)
关键词 慢性阻塞性肺疾病 细胞凋亡 BAX BCL-2 chronic obstructive pulmonary disease apoptosis Bax Bcl-2
  • 相关文献

参考文献12

  • 1Rabe K F,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532-555. 被引量:1
  • 2胡瑞成,徐永健,张珍祥.D2S388、D2S2232微卫星长度多态性与汉族人慢性阻塞性肺疾病易感性关联研究[J].华中科技大学学报(医学版),2007,36(1):45-48. 被引量:3
  • 3Imai K,Mercer B A,Schulman L L,et al.Correlation of lung surface area to apoptosis and proliferation in human emphysema[J].Eur Respir J,2005,25(2):250-258. 被引量:1
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 5Tuder R M,Zhen L,Cho C Y,et al.Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade[J].Am J Respir Cell Mol Biol,2003,29(1):88-97. 被引量:1
  • 6Renda T,Baraldo S,Pelaia G,et al.Increased activation of p38 MAPK in COPD[J].Eur Respir J,2008,31(1):62-69. 被引量:1
  • 7Hanaoka T,Nakayama J,Haninda M,et al.Immunohistochemical demonstration of apoptosis-regulated proteins,Bcl-2 and Bax,in resected non-small-cell lung cancers[J].Int J Clin Oncol,2002,7(3):152-158. 被引量:1
  • 8汤睿,朱正纲.凋亡途径与肿瘤治疗[J].世界华人消化杂志,2005,13(20):2469-2472. 被引量:27
  • 9Patel B D,Coxson H O,Pillai S G,et al.Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2008,178(5):500-505. 被引量:1
  • 10Aoshiba K,Yokohori N,Nagai A.Alveolar wall apoptosis c-auses lung destruction and emphysematous changes[J].Am J Respir Cell Mol Biol,2003,28(4):555-562. 被引量:1

二级参考文献12

共引文献8259

同被引文献39

  • 1兰岚,高占成.慢性阻塞性肺疾病急性加重的发病机制[J].国际呼吸杂志,2007,27(3):203-206. 被引量:24
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1793
  • 3Celli B R,MacNee W,ATS/ERS Task Force.Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper[J].Eur Respir J,2004,23(6):932-946. 被引量:1
  • 4张珍祥.慢性阻塞性肺疾病[M] //叶任高,陆再英.内科学.第6版.北京:人民卫生出版社,2005:60-61. 被引量:1
  • 5Celli B R,Cote C C,Marin J M,et al.The body-mass index,airflow obstruction dyspnea and exercise capacity index in chronic obstructive pulmonary disease[J].N Engl J Med,2004,350(10):1005-1012. 被引量:1
  • 6Mahler D A,Wells C K.Evaluation of clinical methods for rating dyspnea[J].Chest,1988,93(3):580-586. 被引量:1
  • 7ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories.ATS statement:guidelines for the six-minute walk test[J].Am J Respir Crit Care Med,2002,166(1):111-117. 被引量:1
  • 8Ong K C,Earnest A,Lu S J.A multidimensional grading system(BODE index)as predictor of hospitalization for COPD[J].Chest,2005,128(6):3810-3816. 被引量:1
  • 9Rabe K F,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532-555. 被引量:1
  • 10Katsura H,Yamada K,Wakabayashi R,et al.The impact of dyspnea and leg fatigue during exercise on health-related quality of life in patients with COPD[J].Respirology,2005,10(4):485-490. 被引量:1

引证文献5

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部